The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact
Posted Apr 15 2010 11:50pm
New report, “The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories - glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil. - Global Market size and company share data for three diabetes care devices market categories – glucose monitoring and insulin delivery. - Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008. - Qualitative analysis of key market trends, market drivers and restraints by categories and segments. - Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical. - Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.